Arintra vs Revvity
Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $21M Series A (Aug 2025) led by Peak XV Partners with Endeavor Health Ventures and YC. Coding Copilot enables 90% faster chart coding. 5%+ revenue uplift, 43%+ fewer denials.
About
Arintra is an AI medical coding platform that autonomously codes clinical charts with no human intervention, delivering measurable improvements in coding accuracy and speed. The company raised $21 million in Series A financing in August 2025 led by Peak XV Partners (formerly Sequoia India/SEA), with Endeavor Health Ventures and Y Combinator as co-investors. The Coding Copilot enables medical coders to work 90% faster by surfacing recommended codes with supporting clinical documentation.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
About
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.